WCM
MBOT icon

WealthBridge Capital Management’s Microbot Medical MBOT Stock Holding History

WealthBridge Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed – – 554
2019
Q1 		$0 Hold
1
– – ﹤0.01% 1030
2018
Q4 		$0 Buy
+1
New +$4 ﹤0.01% 962

Other funds holding MBOT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WealthBridge Capital Management's MBOT Position: Q2 2019 in Review

WealthBridge Capital Management sold out of Microbot Medical (MBOT) in Q2 2019, closing a stake of 1 share.

WealthBridge Capital Management first reported a position in MBOT in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 30 funds tracked by Wall St. Rank hold MBOT as of Q2 2019.

  • WealthBridge Capital Management reported no remaining Microbot Medical position as of Q2 2019 after selling out during the quarter.
  • WealthBridge Capital Management sold 1 Microbot Medical share in Q2 2019.
  • WealthBridge Capital Management first reported a position in Microbot Medical in Q4 2018 and held it in 2 quarters.
  • WealthBridge Capital Management's Microbot Medical position peaked at $0 in Q1 2019.
  • 30 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2019.

Based on WealthBridge Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.